GoldenGolden
Jazz Pharmaceuticals

Jazz Pharmaceuticals

A biopharmaceutical company engaged in the discovery, development and commercializing of pharmaceutical products

Jazz Pharmaceuticals is a biopharmaceutical company that is dedicated to bringing life-changing medicines to the people who have limited or no options, so they can fully live their lives. The company focuses on developing medicines for people living with serious diseases, often presented with limited or no options, so they can fully live their lives.

The company is working to give people the opportunity to redefine what is possible to make the “small wins” big again, by transforming biopharmaceutical discoveries into novel medicines.

It is an integrated growing biopharmaceutical company that has a diverse portfolio of marketed medicines and novel product candidates in two key therapeutic areas: neuroscience and oncology. The company is an industry leader in epilepsy and sleeping disorders, and Jazz is growing its presence in oncology in hematologic malignancies and solid tumors.

Across its commercial franchises and development programs, Jazz Pharmaceuticals focuses on innovative therapies and support for adults and children living with these conditions. The company explores new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies.

Timeline

February 16, 2021
Jazz Pharmaceuticals announces the completion of the rolling submission for the supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration seeking marketing approval for XywavTM (calcium, magnesium, potassium, and sodium oxybates) oral solution for the treatment of adult patients with idiopathic hypersomnia.
February 3, 2021
Jazz Pharmaceuticals will acquire CBD drugmaker GW Pharma for $7.2 billion

People

Name
Role
LinkedIn

Akaash Mungale

Employee

Alberto Nobrega

Employee

Andrew Mitchell

Employee

Anthony Muchai

Employee

Aubrey Chen

Employee

Audrey Cantley

Employee

Brydon Raethel

Employee

Celine Bernard

Employee

Cristina Gil

Employee

Cuiping "Tracy" Chen

Employee

Cyril De Colle

Employee

Dan Epstein

Employee

DEborah Sanchez

Employee

Doug Ellwood

Employee

Franklin Lowe

Employee

Glenda Lewis

Employee

Greg Ballou

Employee

Ivy Bond

Employee

Jay Bhatia

Employee

Jim Tananbaum

Founder

John Buergenthal

Employee

John Mahon

Employee

John S. Morris

Employee

Justin Hewitt

Employee

Justin Marxer

Employee

Page 1 of 2

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Jazz Pharmaceuticals plc
June 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 13 abstracts sponsored by Jazz Pharmaceuticals and five abstracts from...
Jazz Pharmaceuticals plc
May 26, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its senior management team will provide a company overview and business and...
Financialmorningpost.com
May 21, 2021
www.prnewswire.com:443
/PRNewswire/ -- For years, some smart investors have been making money from the healthcare sector...Cutting-edge healthcare technologies and trends such as...
NetworkNewsWire
May 20, 2021
www.prnewswire.com:443
/PRNewswire/ -- Before government legislation brought the world of psychedelic drug compounds to a halt, promising research was being done in the space. As...
Jazz Pharmaceuticals plc
May 20, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it and its investigator sponsors will present four new abstracts at the virtual...
Bionical Emas
May 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- Bionical Emas, a global specialist Clinical Research Organization (CRO), has today announced the launch of a U.S. Expanded Access Program for...
Jazz Pharmaceuticals plc
May 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its senior management team will provide a company overview and business and...
Jazz Pharmaceuticals plc
May 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2021 and affirmed financial guidance for...
Jazz Pharmaceuticals plc
April 29, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company" or "Jazz") today announced the closing of its previously announced offering (the...
BioSpace
April 23, 2021
BioSpace
GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (Jazz) today announced that GW's shareholders voted to approve the acquisition of GW by a subsidiary of Jazz (or its nominee(s)) at the GW shareholder meetings held today.
Jazz Pharmaceuticals plc
April 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company" or "Jazz") today announced the pricing of the previously announced offering (the...
BioSpace
April 22, 2021
BioSpace
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for serious rare and ultra-rare diseases, announced today the appointment of Kim Sablich to its Board of Directors.
Jazz Pharmaceuticals plc
April 20, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive results from the Phase 3 study of XywavTM (calcium, magnesium, potassium, and...
April 12, 2021
BioSpace
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for XywavTM (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Idiopathic Hypersomnia - read this article along with other careers information, tips and advice on BioSpace
Jazz Pharmaceuticals plc
April 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review...
Jazz Pharmaceuticals plc
February 23, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2020 and provided financial...
Jazz Pharmaceuticals plc
February 16, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the completion of the rolling submission for the supplemental New Drug Application...
Jazz Pharmaceuticals plc
February 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 fourth quarter and full year financial results on Tuesday,...
Jeremy Berke and Yeji Jesse Lee
February 5, 2021
Business Insider
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.
Moore Kuehn, PLLC
February 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.